HEADER IMMUNE SYSTEM/INHIBITOR 05-MAR-23 8GDG TITLE SOLUTION STRUCTURE OF THE NEUTROPHIL SERINE PROTEASE INHIBITOR, EAPH2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL SURFACE LIKE-PROTEIN MAP-W; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 1280; SOURCE 4 GENE: MAP_1, NCTC10702_01500, SAGV69_01671; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS PROTEASE, PROTEASE INHIBITOR, ENZYME KINETICS, INNATE IMMUNITY, KEYWDS 2 IMMUNE EVASION, IMMUNE SYSTEM, IMMUNE SYSTEM-INHIBITOR COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR N.B.MISHRA,B.V.GEISBRECHT,O.PRAKASH REVDAT 4 15-MAY-24 8GDG 1 REMARK REVDAT 3 19-JUL-23 8GDG 1 JRNL REVDAT 2 05-JUL-23 8GDG 1 JRNL REVDAT 1 26-APR-23 8GDG 0 JRNL AUTH N.MISHRA,T.J.HERDENDORF,O.PRAKASH,B.V.GEISBRECHT JRNL TITL SIMULTANEOUS INHIBITION OF TWO NEUTROPHIL SERINE PROTEASES JRNL TITL 2 BY THE S. AUREUS INNATE IMMUNE EVASION PROTEIN EAPH2. JRNL REF J.BIOL.CHEM. V. 299 04878 2023 JRNL REFN ESSN 1083-351X JRNL PMID 37269950 JRNL DOI 10.1016/J.JBC.2023.104878 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8GDG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1000272395. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM [U-100% 13C; U-100% 15N] REMARK 210 EAPH2, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-15N NOESY; 3D 1H-15N REMARK 210 TOCSY; 3D CBCA(CO)NH; 3D HNCO; REMARK 210 3D HNCA; 3D H(CCO)NH; 2D 1H-15N REMARK 210 HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE NEO; AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 4.1, NMRPIPE, CARA REMARK 210 1.9.1, CYANA 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 4 -75.55 -53.12 REMARK 500 1 PRO A 10 -171.29 -69.77 REMARK 500 1 ALA A 15 -74.45 -52.05 REMARK 500 1 LYS A 16 109.20 -169.39 REMARK 500 1 ALA A 99 121.68 -177.72 REMARK 500 2 GLU A 17 171.24 -52.59 REMARK 500 2 ASN A 100 139.03 -176.15 REMARK 500 3 PRO A 10 -170.66 -69.76 REMARK 500 3 ALA A 11 60.43 63.97 REMARK 500 3 LYS A 16 -75.11 -71.96 REMARK 500 3 ALA A 99 118.20 -168.42 REMARK 500 3 ASN A 100 137.06 -177.45 REMARK 500 4 ALA A 4 62.00 -105.81 REMARK 500 4 PRO A 10 -170.79 -69.79 REMARK 500 4 ALA A 15 -55.69 -138.35 REMARK 500 4 ASN A 34 33.03 -95.50 REMARK 500 4 ASN A 100 140.80 -176.61 REMARK 500 5 ALA A 4 61.91 -115.91 REMARK 500 5 ALA A 15 -75.44 -82.60 REMARK 500 5 ASN A 34 -166.81 -179.51 REMARK 500 5 ALA A 99 86.53 -68.31 REMARK 500 6 ALA A 4 55.08 -95.41 REMARK 500 6 PRO A 10 86.16 -69.77 REMARK 500 6 ASN A 34 32.09 -95.49 REMARK 500 6 ALA A 99 106.06 -179.52 REMARK 500 7 ALA A 15 -75.53 -130.89 REMARK 500 7 LYS A 94 44.65 -142.06 REMARK 500 7 ALA A 99 132.46 -176.44 REMARK 500 7 ASN A 100 139.08 -174.52 REMARK 500 8 ALA A 4 59.44 -100.90 REMARK 500 8 ALA A 15 58.06 -104.94 REMARK 500 8 ASN A 34 48.44 -107.07 REMARK 500 8 ALA A 99 91.76 -166.97 REMARK 500 9 ALA A 4 54.89 -107.40 REMARK 500 9 PRO A 10 85.08 -69.72 REMARK 500 9 ASP A 95 106.35 -163.60 REMARK 500 9 TYR A 97 68.67 -119.98 REMARK 500 9 ALA A 99 87.48 -170.92 REMARK 500 10 ALA A 4 -67.50 -93.95 REMARK 500 10 PRO A 10 -179.66 -69.86 REMARK 500 10 GLN A 13 131.01 -171.73 REMARK 500 10 LYS A 14 -62.87 -122.45 REMARK 500 10 GLN A 35 43.93 -86.66 REMARK 500 11 ALA A 4 44.82 -97.35 REMARK 500 11 THR A 12 -66.55 -91.25 REMARK 500 11 THR A 98 85.39 -68.83 REMARK 500 12 SER A 2 -60.53 -101.86 REMARK 500 12 LYS A 16 -64.41 -93.41 REMARK 500 12 ASN A 34 44.74 -91.81 REMARK 500 12 ALA A 99 100.53 -179.13 REMARK 500 REMARK 500 THIS ENTRY HAS 84 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 27540 RELATED DB: BMRB DBREF1 8GDG A 4 117 UNP A0A380EFL1_STAAU DBREF2 8GDG A A0A380EFL1 17 130 SEQADV 8GDG GLY A 1 UNP A0A380EFL EXPRESSION TAG SEQADV 8GDG SER A 2 UNP A0A380EFL EXPRESSION TAG SEQADV 8GDG THR A 3 UNP A0A380EFL EXPRESSION TAG SEQRES 1 A 117 GLY SER THR ALA GLU LYS ASP LYS LEU PRO ALA THR GLN SEQRES 2 A 117 LYS ALA LYS GLU MET GLN ASN VAL PRO TYR THR ILE ALA SEQRES 3 A 117 VAL ASP GLY ILE MET ALA PHE ASN GLN SER TYR LEU ASN SEQRES 4 A 117 LEU PRO LYS ASP SER GLN LEU SER TYR LEU ASP LEU GLY SEQRES 5 A 117 ASN LYS VAL LYS ALA LEU LEU TYR ASP GLU ARG GLY VAL SEQRES 6 A 117 THR PRO GLU LYS ILE ARG ASN ALA LYS SER ALA VAL TYR SEQRES 7 A 117 THR ILE THR TRP LYS ASP GLY SER LYS LYS GLU VAL ASP SEQRES 8 A 117 LEU LYS LYS ASP SER TYR THR ALA ASN LEU PHE ASP SER SEQRES 9 A 117 ASN SER ILE LYS GLN ILE ASP ILE ASN VAL LYS THR LYS HELIX 1 AA1 SER A 47 ARG A 63 1 17 HELIX 2 AA2 GLU A 68 ALA A 73 1 6 HELIX 3 AA3 LYS A 93 ASP A 95 5 3 SHEET 1 AA1 3 ILE A 30 MET A 31 0 SHEET 2 AA1 3 GLN A 19 VAL A 27 -1 N VAL A 27 O ILE A 30 SHEET 3 AA1 3 TYR A 37 LEU A 40 -1 O LEU A 38 N VAL A 21 SHEET 1 AA2 5 ILE A 30 MET A 31 0 SHEET 2 AA2 5 GLN A 19 VAL A 27 -1 N VAL A 27 O ILE A 30 SHEET 3 AA2 5 ILE A 107 LYS A 115 1 O ILE A 112 N THR A 24 SHEET 4 AA2 5 SER A 75 TRP A 82 -1 N THR A 81 O GLN A 109 SHEET 5 AA2 5 LYS A 87 ASP A 91 -1 O VAL A 90 N TYR A 78 SHEET 1 AA3 2 GLN A 45 LEU A 46 0 SHEET 2 AA3 2 PHE A 102 ASP A 103 -1 O PHE A 102 N LEU A 46 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1